IDT, Ubiquitome Partner to Develop Mobile Ebola Test | GenomeWeb

NEW YORK (GenomeWeb) ― New Zealand startup Ubiquitome and custom oligo supplier Integrated DNA Technologies (IDT) announced a new partnership today to develop a hand-held Ebola assay.

The assay will be developed by IDT using the firm's PrimeTime qPCR Assay components. It will run on Ubiquitome's hand-held PCR platform, the Freedom4.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.